Less Use of NSAIDs in Long-Term than in Recent Chondroitin Sulphate Users in Osteoarthritis: a Pharmacy-based Observational Study in France
Thérapie, 61 4 (2006) 341-346
Published online: 2007-02-07
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment
Jean-Yves Reginster and Nicola VeroneseAging Clinical and Experimental Research 33 (1) 37 (2021)
https://doi.org/10.1007/s40520-020-01643-8
Access to Highly Purified Chondroitin Sulfate for Appropriate Treatment of Osteoarthritis: A Review
Xavier Chevalier and Thierry ConrozierMedicine Access @ Point of Care 1 (2017)
https://doi.org/10.5301/maapoc.0000022
Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study
Lucio C. Rovati, Federica Girolami, Massimo D’Amato and Giampaolo GiacovelliSeminars in Arthritis and Rheumatism 45 (4) S34 (2016)
https://doi.org/10.1016/j.semarthrit.2015.10.009
Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis
Maxime Dougados, Emily Wood, Laure Gossec, et al.The Journal of Rheumatology 42 (12) 2361 (2015)
https://doi.org/10.3899/jrheum.150378
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Olivier Bruyère, Cyrus Cooper, Jean-Pierre Pelletier, Jaime Branco, Maria Luisa Brandi, Francis Guillemin, Marc C. Hochberg, John A. Kanis, Tore K. Kvien, Johanne Martel-Pelletier, René Rizzoli, Stuart Silverman and Jean-Yves ReginsterSeminars in Arthritis and Rheumatism 44 (3) 253 (2014)
https://doi.org/10.1016/j.semarthrit.2014.05.014
What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
Yves Henrotin, Marc Marty and Ali MobasheriMaturitas 78 (3) 184 (2014)
https://doi.org/10.1016/j.maturitas.2014.04.015
An economic evaluation of chondroitin sulfate and non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis. Data from the VECTRA study
Carlos Rubio-TerrésReumatología Clínica (English Edition) 6 (4) 187 (2010)
https://doi.org/10.1016/S2173-5743(10)70043-5
Evaluación económica del uso de condroitín sulfato y antiinflamatorios no esteroideos en el tratamiento de la artrosis. Datos del estudio VECTRA
Carlos Rubio-TerrésReumatología Clínica 6 (4) 187 (2010)
https://doi.org/10.1016/j.reuma.2009.12.009
Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
Alain Jacquet, Pierre-Olivier Girodet, Antoine Pariente, Karelle Forest, Laurent Mallet and Nicholas MooreArthritis Research & Therapy 11 (6) (2009)
https://doi.org/10.1186/ar2891
Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique
K D RainsfordJournal of Pharmacy and Pharmacology 61 (10) 1263 (2009)
https://doi.org/10.1211/jpp.61.10.0001